Treatment of neuropsychiatric symptoms in patients with dementia

New England Journal of Medicine

Volumn 357, Issue 14, 2007, Pages 1441-1443

  Yaffe, Kristine ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE; INDAN DERIVATIVE; PIPERIDINE DERIVATIVE;

AGITATION; ALZHEIMER DISEASE; AROMATHERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; DEMENTIA; DRUG WITHDRAWAL; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HUMAN; MENTAL DISEASE; MORBIDITY; MUSIC THERAPY; NEUROPSYCHIATRY; OUTCOME ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; UNSPECIFIED SIDE EFFECT; AGED; NOTE; PATIENT SELECTION; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; RESTLESSNESS; SOCIAL SUPPORT; TREATMENT FAILURE;

AGED; ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; CHOLINESTERASE INHIBITORS; HUMANS; INDANS; PATIENT SELECTION; PIPERIDINES; PSYCHOMOTOR AGITATION; PSYCHOTHERAPY; SOCIAL SUPPORT; TREATMENT FAILURE;

EID: 34948881867     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe078128     Document Type: Editorial

References (9)

1. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the Cardiovascular Health Study. JAMA 2002;288:1475-83.
2. Yaffe K, Fox P, Newcomer R, et al. Patient and caregiver characteristics and nursing home placement in patients with dementia. JAMA 2002;287:2090-7.
3. Trinh NH, Hoblyn J, Mohanty S, Yaffe K. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. JAMA 2003;289:210-6.
4. Howard RJ, Juszczak E, Ballard CG, et al. Donepezil for the treatment of agitation in Alzheimer's disease. N Engl J Med 2007;357:1382-92.
5. Gauthier S, Feldman H, Hecker J, et al. Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease. Int Psychogeriatr 2002;14:389-404.
6. Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005;293:596-608.
7. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005;294:1934-43.
8. Schneider LS, Tariot PN, Dagerman KS, et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med 2006;355:1525-38.
9. Ayalon L, Gum AM, Feliciano L, Areán PA. Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review. Arch Intern Med 2006;166:2182-8.